Pancreatitis Trial, Recruiting NCT07117318 Sponsor: Air Force Military Medical University, China Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT07117318
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 90 years old and are scheduled to have a procedure called ERCP (a procedure that examines the bile and pancreatic ducts) with an untouched natural opening (papilla) in your digestive tract.
  • You are considered at higher risk of developing a complication called pancreatitis (inflammation of the pancreas) after ERCP, which may include any one of the following: your doctor suspects a condition where the valve controlling bile and pancreatic fluid doesn't work properly; you have had pancreatitis after a previous ERCP; you need a specific type of cutting or widening procedure on the pancreatic valve; the doctor had difficulty accessing the bile duct during the procedure; or a balloon was used to widen the bile duct opening for a short time.
  • You may also be considered higher risk if you meet two or more of these additional factors: you are a woman under 50 years old; you have had two or more episodes of pancreatitis in the past; dye was injected deeply into the pancreatic duct three or more times; a tiny part of the pancreas called the acini was highlighted during the procedure; or a brushing sample was taken from the pancreatic duct (confirm with trial site).

Who may not be able to join:

  • You have previously had a cutting procedure on the bile duct opening or a large balloon widening of that area.
  • You are planned to have a stent (a small tube) placed in your pancreatic duct, for example due to a narrowing or a planned removal of a growth in that area.
  • You have an allergy to anti-inflammatory painkillers known as NSAIDs (such as ibuprofen or diclofenac).
  • You have taken NSAIDs within the 7 days before the procedure.
  • NSAIDs are not considered safe for you — for example, you have had a gastrointestinal bleed within the past 4 weeks, your kidneys are not working well enough, or you have a blood clotting problem.
  • You have had a flare-up of pancreatitis within 7 days before the ERCP, or you currently have pancreatitis with swelling around the pancreas or fluid collections nearby.
  • You are in an unstable or critical medical condition affecting your blood pressure or circulation.
  • You are pregnant or currently breastfeeding.
  • You are a higher-risk patient where a guidewire has been passed through the pancreatic duct during the procedure (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Air Force Military Medical University, China
Registry
ClinicalTrials.gov
Start date
1 July 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Rate of post-ERCP Pancreatitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov